Correlation Between Unicycive Therapeutics and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Viridian Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Viridian Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Viridian Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Unicycive and Viridian is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Viridian Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 2.45 times more return on investment than Viridian Therapeutics. However, Unicycive Therapeutics is 2.45 times more volatile than Viridian Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 73.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 5.10 from holding Unicycive Therapeutics or generate 6.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Viridian Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Viridian Therapeutics |
Unicycive Therapeutics and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Viridian Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |